Corbus Pharmaceuticals Holdings (CRBP) EBT Growth (3y) (2016 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EBT Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 32.96% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 28.95% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -49.71% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 20.92% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 12.01% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 143.80 Mn | 115.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28.82% |
| Jun 30, 2025 | -15.78% |
| Mar 31, 2025 | -32.42% |
| Dec 31, 2024 | 29.62% |
| Sep 30, 2024 | 28.25% |
| Jun 30, 2024 | 27.17% |
| Mar 31, 2024 | 26.25% |
| Dec 31, 2023 | 19.06% |
| Sep 30, 2023 | 32.46% |
| Jun 30, 2023 | 37.77% |
| Mar 31, 2023 | 16.57% |
| Dec 31, 2022 | 26.36% |
| Sep 30, 2022 | 30.91% |
| Jun 30, 2022 | -97.72% |
| Mar 31, 2022 | 31.23% |
| Dec 31, 2021 | 16.78% |
| Sep 30, 2021 | 1.75% |
| Jun 30, 2021 | -11.26% |
| Mar 31, 2021 | -9.75% |
| Dec 31, 2020 | -24.72% |